Retatrutide, an investigational molecule by Eli Lilly and Company, is emerging as a promising therapeutic agent in the field of obesity management. Revealed in phase 2 trials, retatrutide has demonstrated significant efficacy in weight reduction among participants with obesity or overweight, achieving a mean weight loss of up to 17.5% over 24 …
⚠️ For research purposes only. Not for human consumption.
Reviews
There are no reviews yet.